‘Switchable’ bispecific antibodies pave way for safer cancer treatment

In the ever-evolving battle against cancer, immunotherapy presents a turning point. It began with harnessing the body’s immune system to fight cancer, a concept rooted more than a century ago but only gaining significant momentum in recent years.

Leave A Comment

Your email address will not be published. Required fields are marked *